PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:04 AM ET

Sponsor Check › Person

DR
No photo found yet (own website and image search run after this page is viewed)

David Ian Rabuka

Named as an officer, director or promoter on SEC Form D filings · CA · Mar 3, 2010 → Mar 26, 2010

3deals (issuers)
$15Mreported sold
38investors
8Form D filings
2010year on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

David Ian Rabuka is listed as an executive officer, director, and promoter on 8 SEC Form D filings by 3 issuers between Mar 2010 and Apr 2022: REDWOOD BIOSCIENCE INC (Emeryville, CA — biotechnology — 2010–2014; $8.65M reported sold to 11 investors), DNAlite Therapeutics, Inc. (San Francisco, CA — biotechnology — 2022; $5.6M reported sold to 18 investors) and ACRIGEN BIOSCIENCES, INC. (Kensington, CA — biotechnology — 2019; $775K reported sold to 9 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer, director, and promoter, over about 12 years. Across those companies the filings report $15M sold in total.

Listed alongside Karen Boezi (7 shared filings), Michael Blank (6 shared filings), Carolyn Bertozzi (4 shared filings), Paul Socolow (4 shared filings), BARRY LITTLEJOHNS (2 shared filings) and 7 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 8 public filings for David Ian Rabuka and found 13 differences, 3 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for David Ian Rabuka has not run yet — it is joining a line of 5,760 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched David Ian Rabuka..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

13 differences found between the filings for David Ian Rabuka — 3 worth asking about (compared 8 filings on Oct 24, 2026)

Worth asking · Mar 3, 2010 – Mar 26, 2010

Amount sold went down between filings — REDWOOD BIOSCIENCE INC

The Mar 3, 2010 filing says $450,000 sold; the Mar 26, 2010 Form D says $300,000 sold — $150,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Sources
Worth asking · Mar 3, 2010 – Mar 26, 2010

Investor count went down between filings — REDWOOD BIOSCIENCE INC

The Mar 3, 2010 filing reports 4 investors; the Mar 26, 2010 Form D reports 2 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Sources
Worth asking · May 12, 2009 – Jul 1, 2019

4 Form Ds were filed more than 15 days after the first sale

Form D filed 295 days after the first sale — REDWOOD BIOSCIENCE INC · Form D filed 167 days after the first sale — REDWOOD BIOSCIENCE INC · Form D filed 17 days after the first sale — ACRIGEN BIOSCIENCES, INC. · Form D filed 23 days after the first sale — REDWOOD BIOSCIENCE INC

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Sources
Note · Mar 26, 2010 – Apr 22, 2013

David Ian Rabuka's role changed at REDWOOD BIOSCIENCE INC: executive officer, director, promoter → executive officer, director

The Mar 26, 2010 filing lists David Ian Rabuka as executive officer, director, promoter; the Apr 22, 2013 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Mar 3, 2010 – Mar 26, 2010

Offering amount lowered between filings — REDWOOD BIOSCIENCE INC

The Mar 3, 2010 filing says $450,000 offered; the Mar 26, 2010 Form D says $300,000.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Sources
Note · Mar 3, 2010

Offering amount changed between filings — REDWOOD BIOSCIENCE INC

The Mar 3, 2010 filing says $1,530 offered; the Mar 3, 2010 Form D says $1,800.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Mar 3, 2010

Offering amount changed between filings — REDWOOD BIOSCIENCE INC

The Mar 3, 2010 filing says $1,800 offered; the Mar 3, 2010 Form D/A says $450,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Apr 1, 2022 – Apr 15, 2022

No amendment in the last 12 months on an offering that may still be open — DNAlite Therapeutics, Inc. (latest filing Apr 15, 2022)

The latest filing for this offering is dated Apr 15, 2022 (first sale Apr 1, 2022). It reports $5,596,650 sold of $8,929,986 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jun 14, 2019 – Jul 1, 2019

No amendment in the last 12 months on an offering that may still be open — ACRIGEN BIOSCIENCES, INC. (latest filing Jul 1, 2019)

The latest filing for this offering is dated Jul 1, 2019 (first sale Jun 14, 2019). It reports $775,000 sold of $1,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Apr 8, 2013 – Apr 22, 2013

No amendment in the last 12 months on an offering that may still be open — REDWOOD BIOSCIENCE INC (latest filing Apr 22, 2013)

The latest filing for this offering is dated Apr 22, 2013 (first sale Apr 8, 2013). It reports $8,648,300 sold of $12,072,201 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Mar 3, 2010 – Apr 22, 2013

David Ian Rabuka is written 2 different ways on the filings

listed as "David Ian Rabuka" on 4 filings (from Mar 3, 2010), and "David Rabuka" on 4 filings (from Apr 22, 2013).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Sources
Note · Mar 26, 2010 – Apr 22, 2013

Address moved from Burlingame, CA to Emeryville, CA — REDWOOD BIOSCIENCE INC

The people listed on the Mar 26, 2010 filing give Burlingame, CA; on the Apr 22, 2013 filing they give Emeryville, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Mar 3, 2010 – Apr 22, 2013

Reported revenue range changed between filings — REDWOOD BIOSCIENCE INC

"No Revenues" (Mar 3, 2010); then "Decline to Disclose" (Apr 22, 2013).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 5 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Apr 15, 2022 D
DNAlite Therapeutics, Inc.
File 021-441983
$0$0$0None listed on this filingEDGAR ↗
Jul 1, 2019 D
ACRIGEN BIOSCIENCES, INC.
File 021-343190
$0$0$0None listed on this filingEDGAR ↗
Jan 28, 2014 D
REDWOOD BIOSCIENCE INC
File 021-210782
$0$0$0None listed on this filingEDGAR ↗
Apr 22, 2013 D
REDWOOD BIOSCIENCE INC
File 021-195304
$0$0$0None listed on this filingEDGAR ↗
Mar 26, 2010 D
REDWOOD BIOSCIENCE INC
File 021-116945
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named David Ian Rabuka on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

DNAlite Therapeutics, Inc.

San Francisco, CA · Apr 15, 2022
  • Apr 15, 2022 · D · $5,596,650 sold of $8,929,986 · 18 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $5.6M from 18 investors (63% of the $8.93M target) as of the latest filing. David is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

ACRIGEN BIOSCIENCES, INC.

Kensington, CA · Jul 1, 2019
  • Jul 1, 2019 · D · $775,000 sold of $1,000,000 · 9 investors · min. No minimum reported · role: Executive Officer, Director, Promoter EDGAR ↗

Raised $775K from 9 investors (78% of the $1M target) as of the latest filing. David is listed as executive officer, director, promoter.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

REDWOOD BIOSCIENCE INC

Emeryville, CA · Mar 3, 2010 → Jan 28, 2014 · 6 filings
  • Jan 28, 2014 · D · $2,499,999 sold of $2,499,999 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Apr 22, 2013 · D · $8,648,300 sold of $12,072,201 · 11 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Mar 26, 2010 · D · $300,000 sold of $300,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director, Promoter EDGAR ↗
  • Mar 3, 2010 · D/A · $450,000 sold of $450,000 · 4 investors · min. No minimum reported · role: Executive Officer, Director, Promoter EDGAR ↗
  • Mar 3, 2010 · D · $1,800 sold of $1,800 · 2 investors · min. No minimum reported · role: Executive Officer, Director, Promoter EDGAR ↗
  • Mar 3, 2010 · D · $1,530 sold of $1,530 · 1 investors · min. No minimum reported · role: Executive Officer, Director, Promoter EDGAR ↗

Raised $8.65M from 11 investors (100% of the $2.5M target) as of the latest filing. David is listed as executive officer, director, promoter on 6 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around David 12

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Karen Boezi

Executive Officer, Director · 7 shared filings (2 issuers)

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Blank

Executive Officer, Promoter, Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

CB
No photo found yet (own website and image search run after this page is viewed)
Person

Carolyn Bertozzi

Promoter · 4 shared filings (1 issuer)

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Socolow

Director · 4 shared filings (1 issuer)

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

EM
No photo found yet (own website and image search run after this page is viewed)
Person

EDWARD MCCRACKEN

Director · 2 shared filings (1 issuer)

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

J GORDON FOULKES

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

BL
No photo found yet (own website and image search run after this page is viewed)
Person

BARRY LITTLEJOHNS

Director · 2 shared filings (1 issuer)

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

DL
No photo found yet (own website and image search run after this page is viewed)
Person

Drew Lanza

Director · 1 shared filing (1 issuer) · also on 7 other issuers

Drew Lanza is on 8 issuers in total — a repeat sponsor. Their page lists every one.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Bondy-Denomy

Director · 1 shared filing (1 issuer)

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Cain McClary

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

MA
No photo found yet (own website and image search run after this page is viewed)
Person

Mubhij Ahmad

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

TD
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy Paul Day

Director · 1 shared filing (1 issuer)

Listed on the same filings as David Ian Rabuka. Their page shows their other deals.

The team behind the deals

Same business address

9 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to David Ian Rabuka by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers David Ian Rabuka is listed on: none on file. No website or social profile named in DNAlite Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #159,197 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Francisco, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when David Ian Rabuka appears on a new Form D, or when a court case or SEC action is matched to them. See plans →